Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > PPS

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Sep 29, 2023 11:10am

110 Views

Post# 35661670

RE:RE:RE:RE:RE:PPS

You really went all in there on you're stupidity.

Hope is yet to trialed in any expansive cancer trials. Maybe start your own oncology company and do some trials yourself.

The only thing you do here is deprive a village somewhere of an idiot. Get on back to your day job.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?